A detailed history of West Bancorporation Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, West Bancorporation Inc holds 5,471 shares of ABBV stock, worth $960,598. This represents 0.74% of its overall portfolio holdings.

Number of Shares
5,471
Previous 5,471 -0.0%
Holding current value
$960,598
Previous $938,000 15.14%
% of portfolio
0.74%
Previous 0.72%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $98,129 - $111,809
-614 Reduced 10.09%
5,471 $996,000
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $10,732 - $12,087
-78 Reduced 1.27%
6,085 $942,000
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $13,225 - $15,310
99 Added 1.63%
6,163 $918,000
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $54,594 - $67,938
412 Added 7.29%
6,064 $817,000
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $83,584 - $96,260
-578 Reduced 9.28%
5,652 $900,000
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $26,278 - $31,515
-190 Reduced 2.96%
6,230 $1.01 Million
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $140,383 - $161,010
-1,046 Reduced 14.01%
6,420 $862,000
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $24,221 - $30,792
-176 Reduced 2.3%
7,466 $1.14 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $966,093 - $1.2 Million
7,320 Added 2273.29%
7,642 $1.24 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $1,826 - $2,310
17 Added 5.57%
322 $44,000
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $20,382 - $30,901
-316 Reduced 50.89%
305 $23,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $44,792 - $56,045
621 New
621 $55,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track West Bancorporation Inc Portfolio

Follow West Bancorporation Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Bancorporation Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Bancorporation Inc with notifications on news.